Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the 12 Best Genomics Stocks to Invest In. Cathie Wood’s ARK Investment acquired 755,000 shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ...

Abstract: This article studies the recursive state estimator-based fuzzy adaptive control scheme for discrete-time uncertain nonlinear systems with state saturations and missing measurements. A fuzzy ...

Abstract: This article irons out the issue of recursive state estimation for mobile robot localization under a multiple description coding scheme. For the sake of optimizing the utilization of channel ...